
Sign up to save your podcasts
Or


We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.
By Retina Synthesis4.5
88 ratings
We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.

43 Listeners

18 Listeners

100 Listeners

111,948 Listeners

56,508 Listeners

5 Listeners

9,532 Listeners

11 Listeners

47,654 Listeners

50 Listeners

11 Listeners

466 Listeners

19 Listeners

0 Listeners